Highlights

  • Argent Biopharma Ltd (ASX: RGT) closed at $0.039 on August 7, 2026.
  • The stock recorded a decline of approximately 2.50 percent for the session.
  • Shares traded within an intraday range of $0.038 to $0.040.
  • Market capitalisation stood at approximately $4.55 million.
  • Trading volume reached 400,274 shares during the session.

Argent Biopharma Ltd (ASX: RGT) shares closed at $0.039 on August 7, 2026, after recording a decline of approximately 2.50 percent during the session. The stock traded within an intraday range of $0.038 to $0.040, while the broader S&P/ASX 200 Health Care Index ended lower after declining 0.92 percent.

Argent Biopharma Share Price Movement on August 7, 2026

The data reviewed showed that Argent Biopharma shares recorded a decline of approximately 2.50 percent during the session. The stock traded between an intraday low of $0.038 and a high of $0.040 before closing at $0.039.

Daily share price movements in biotechnology companies can vary depending on company-specific developments, market participation, sector sentiment and broader market conditions. The session’s movement represents short-term trading activity and should be considered alongside longer-term performance trends.

Trading Volume and Market Capitalisation

Trading volume for Argent Biopharma reached 400,274 shares during the session. Based on the closing share price, the company’s market capitalisation stood at approximately $4.55 million.

The trading activity reflected participation in the stock during the session, while the market capitalisation placed Argent Biopharma among the smaller-capitalisation companies within the ASX health care sector.

One-Year Share Price Performance

Over the trailing one-year period, Argent Biopharma recorded a decline of approximately 46.58 percent based on the data reviewed.

Smaller biotechnology companies can experience changes in share price over time due to company-specific developments, research activities, funding considerations, sector conditions and broader investor sentiment.

ASX Health Care Sector Performance

The broader S&P/ASX 200 Health Care Index (XHJ) closed at 27,976.2 points on August 7, 2026, down 259.3 points or 0.92 percent.

The index recorded a day high of 28,235.5 points and a day low of 27,808.8 points, compared with a previous close of 28,235.5 points. Over the past 52 weeks, the index traded between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.44 percent.

Individual health care stocks can record movements that differ from the broader index due to company-specific factors, trading volumes and changes in investor participation.

About Argent Biopharma Ltd

Argent Biopharma Ltd is listed on the ASX under the ticker code RGT and operates within the health care sector.

Companies operating within biotechnology can experience share price movements influenced by research developments, market expectations, sector conditions and broader movements across health care stocks.

Understanding the Trading Data

The share price, trading volume and market capitalisation figures provide an overview of Argent Biopharma’s market activity during the reviewed session.

Trading volume represents the number of shares exchanged during the session, while market capitalisation reflects the market value based on the closing share price and shares on issue. Daily price movements provide a snapshot of market activity during a specific period and do not necessarily indicate longer-term performance.

Conclusion

Argent Biopharma Ltd (ASX: RGT) shares closed at $0.039 on August 7, 2026, after recording a decline of approximately 2.50 percent during the session. The stock traded within a range of $0.038 to $0.040, with trading volume of 400,274 shares and market capitalisation of approximately $4.55 million.

The broader S&P/ASX 200 Health Care Index closed lower at 27,976.2 points, down 0.92 percent. Over the trailing one-year period, Argent Biopharma recorded a decline of approximately 46.58 percent based on the data reviewed.